Y-mAbs Therapeutics, Inc. (YMAB)
NASDAQ: YMAB · IEX Real-Time Price · USD
16.04
+0.83 (5.46%)
May 1, 2024, 11:39 AM EDT - Market open
Y-mAbs Therapeutics Revenue
In the year 2023, Y-mAbs Therapeutics had annual revenue of $84.82M with 29.96% growth. Revenue in the quarter ending December 31, 2023 was $23.36M, a -25.71% decrease year-over-year.
Revenue (ttm)
$84.82M
Revenue Growth
+29.96%
P/S Ratio
7.85
Revenue / Employee
$848,190
Employees
100
Market Cap
701.31M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 84.82M | 19.55M | 29.96% |
Dec 31, 2022 | 65.27M | 30.37M | 87.03% |
Dec 31, 2021 | 34.90M | 14.15M | 68.18% |
Dec 31, 2020 | 20.75M | - | - |
Dec 31, 2019 | 0 | - | - |
Dec 31, 2018 | 0 | - | - |
Dec 31, 2017 | 0 | - | - |
Dec 31, 2016 | 0 | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Phibro Animal Health | 982.01M |
Varex Imaging | 877.80M |
Pharming Group | 272.57M |
Treace Medical Concepts | 187.12M |
OrthoPediatrics | 148.73M |
Autolus Therapeutics | 1.70M |
YMAB News
- 5 days ago - Y-mAbs to Announce First Quarter 2024 Financial and Operating Results on May 7, 2024 - GlobeNewsWire
- 5 days ago - Y-mAbs to Present at 2024 ASCO Annual Meeting - GlobeNewsWire
- 6 weeks ago - Y-mAbs Therapeutics Announces Resignation of Chief Financial Officer - GlobeNewsWire
- 2 months ago - Y-mAbs Appoints Oncology Executive Mary Tagliaferri, M.D. to its Board of Directors - GlobeNewsWire
- 2 months ago - Y-mAbs Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Developments - GlobeNewsWire
- 2 months ago - Y-mAbs to Announce Fourth Quarter and Full Year 2023 Financial and Operating Results on February 29, 2024 - GlobeNewsWire
- 4 months ago - Y-mAbs Therapeutics to Present at 42nd Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 4 months ago - Y-mAbs Therapeutics Added to the NASDAQ Biotechnology Index - GlobeNewsWire